Objectives To assess physician perspectives on perceived barriers and facilitators to type 2 diabetes self-management (DSM) in a primary care setting. Methods The study utilized survey methodology to measure perspectives of primary care physicians on DSM and the challenges they face in managing patients with poor glycaemic stability. Demographic and practice site-related information of the physicians were also collected. Key findings Of the 21 physicians who responded (53.8% response rate), 71.2% were aged 50 years or older, 54.2% had ≥25 years of clinical experience, and 50% practiced in an urban setting. The physicians examined 5-60 patients with type 2 diabetes per week (mean = 20), and over 75% of them spent <20 min on face-to-face visits. Approximately, 95% of physicians considered self-care activities such as regular moderate exercise, following a recommended diet, regular blood glucose testing, proper insulin administration and adherence to oral medication as extremely important. Practice-related aspects such as patient-physician communication, patient health literacy and patient follow-up were unanimously considered extremely important, and performance on these measures was rated positively. Interestingly, 66% of physicians felt responsible to some extent for their patient's failure to reach type 2 DSM goals. Physician perceived barriers that contributed to clinical inertia included cost of medications, lack of patient motivation and knowledge, non-compliance with diet and medications, polypharmacy and lack of time and social support. Conclusions The study results underscore the importance of DSM in the overall management of type 2 diabetes. Addressing the challenges faced by physicians may result in better self-management and improved clinical outcomes in type 2 diabetes population.
Introduction
'Diabetes self-management (DSM)' is an essential component of diabetes care in patients with type 2 diabetes (T2DM) and is associated with glycaemic stability, enhanced quality of life and improved psychosocial functions. [1] Although patients with T2DM may eventually require pharmacologic treatment(s) along with DSM to effectively manage their disease; glycaemic stability reduces the risk of disease progression and related complications. [2, 3] More than half the patients with T2DM fail to achieve the globally recognized target A1C levels despite the advances in treatments. [3] Their failure to achieve glycaemic stability is attributed to patient-related factors such as lack of knowledge, comorbidities, financial resources (e.g. personal cost of care), nonadherence to therapy and physicianrelated factors such as beliefs, attitudes, knowledge, communication with patients, type of healthcare system and clinical inertia. [4] [5] [6] [7] [8] [9] [10] [11] [12] 'Clinical Inertia' or 'Therapeutic Inertia' is defined as the lack of treatment intensification by physicians in patients who are not on 'evidence-based goals' for care. Factors contributing to clinical inertia include time and resource constraints, cautious prescribing behaviour to avoid side effects, lack of understanding of patient needs, failure to set treatment goals and insufficient follow-up with patients to reach their selfmanagement goals. [3, 13] Experts recommend a shift in patient-physician interactions to facilitate self-management, advocating for shared decision making (joint definition of problems, treatment goals, and management strategies) and enhanced physician-patient communication. [14] Identifying barriers and facilitators to self-management and addressing them is a critical step in achieving improved health outcomes in T2DM. Existing literature focuses mainly on patient-related factors and less so on primary care physician (PCP) factors including physician-patient interactions. [15] [16] [17] A disconnect between the patient's and PCP's perceptions, knowledge and attitudes can cause confusion and conflict, which may potentially lead to poor patient health outcomes. [15, 17] In addition to exploring factors responsible for patient's nonresponsiveness to their therapy, a better understanding of PCP's perceptions could potentially help improve diabetes care and in turn, promote better self-management in their patients. This study is part of a larger study that assessed barriers and facilitators to DSM from the perspectives of patients as well as their PCPs. [18] The focus of this paper is on PCP perspectives. Specifically, the study aimed to identify PCP perspectives on perceived barriers to self-management and explore the challenges they face in improving self-management in their patients with T2DM.
Methods

Study design
This study surveyed PCPs from a large physician group based in the southwestern region of Pennsylvania, about their perspectives on barriers and facilitators they encounter in managing patients with unstable T2DM. The physician group consisted of 39 PCPs, and the survey was administered at a monthly meeting of the physician group in 2014.
Physician survey
The PCP survey consisted of five sections and utilized both open-and closed-ended questions. Section A (five questions) focused on physician perceptions about patient selfcare activities. Specifically, the questions probed how important and difficult the PCPs perceived self-care activities for their patients including regular moderate exercise, following a recommended diet, regular blood glucose testing, proper insulin administration and adherence to oral medications. This section also asked the PCPs about the proportion of their patients they believed were adherent to these self-care activities. Section B (three questions) focused on physician views about their clinical practice and assessed the following: how important the PCPs believed aspects of their practice such as physician-patient communication, patient health literacy and patient follow-up, how the PCPs rated their performance on these measures and how satisfied they were with their performance. Sections C (four questions) and E (eight questions) collected practice-related and demographic information of the PCPs respectively. Section D utilized an open-ended question to identify the challenges PCPs encountered in managing patients whose A1C levels are not optimal (A1C >7).
The questionnaire was examined for its face validity and content validity through expert opinions (investigators, PCPs and pharmacist from the physician group) assessing whether the items in the questionnaire measure the above objectives adequately and completely. The items which seemed not useful were removed from the questionnaire and those that received consensus among the experts were included in the final questionnaire.
Statistical analysis plan
Descriptive statistics were conducted to report the demographic and practice characteristics of responding PCPs. Means and standard deviations were reported for continuous variables such as age and years in practice. Frequencies and percentages were reported for categorical variables such as PCPs feeling responsible for patient's failure to reach self-management goals. PCP perceptions about their patient's self-management behaviours and their beliefs about their practices were summarized as responses on a 5-point Likert scale. The qualitative component of the physician survey probed the PCPs regarding the challenges they face in improving their patient's self-management of T2DM. Recurrent themes were identified manually using techniques suggested by Ryan and Bernard (repetitions, cutting and sorting, similarities and differences), and the most common themes were reported. [19] All other statistical analyses were conducted using IBM SPSS (IBM Corp. 
Results
The target sample was composed of PCPs working in the physician group (n = 39) out of which 24 responses were received. The respondents included 21 PCPs and three medical staff members (one physician assistant, one transitionof-care liaison and one nurse practitioner). Since the study objective was to assess the barriers to DSM as perceived by physicians, who were directly involved in treating patients, the analyses included responses from the 21 PCPs only, for a response rate of 53.8%.
Demographic and practice characteristics
The PCPs were all males, and 71.42% were older than 50 years of age (mean = 53.81 AE 8.93). Over 50% (13 out of 21) of the PCPs had more than 25 years of clinical experience (mean = 23.90 AE 9.19), and over 50% had their practice in an urban setting. The PCPs examined 5-60 patients with T2DM per week (mean = 20.95 AE 12.06), and a majority of PCPs (76.20%) spent <20 min on face-toface visits ( Table 1) .
The survey enquired about other attributes of the PCPs' practices such as the number of face-to-face interactions with patients in a 3-month period and the number of follow-ups conducted between two face-to-face interactions.
A majority of PCPs had 1-2 face-to-face interactions with their patients with T2DM every 3 months. Interestingly, around 20% of the PCPs interacted face-to-face with their T2DM patients more than five times in a 3-month interval. Patient follow-up was conducted by over 80% of the PCPs, with 14.28% PCPs following up with their patients at least three times between two face-to-face visits. Because followup care was offered by all the participating physician offices, the survey enquired about the reasons for not receiving follow-up care in patients who did not receive/ seek follow-up care. A majority of the PCPs (57.10%) agreed that follow-up care was not sought by some patients as the patients felt that they had adequate knowledge of the disease and thus, did not require any follow-ups. The PCPs did not believe that their lack of contact with patients was a reason for no follow-up. Around 19% of the PCPs believed that lack of time to interact with patients was a possible reason for not following up with their patients while 23.8% of the PCPs believed that patients could not afford follow-up care. Interestingly, lack of internal support such as staff, funding and materials and equipment was not considered a reason for 'no follow-up' by over 80% of the PCPs. PCPs mostly cited patient-related factors such as nonadherence, patient indifference and patient's lack of concern for their own health and their inability to keep up with appointments as possible reasons for lack of follow-up.
The PCPs were requested to report the reasons for referring their patients to an endocrinologist. Unstable nature of their patient's disease (90.5%, n = 19), need for insulin therapy or insulin pump (28.6%, n = 6), noncompliance and poor adherence (28.6%, n = 6) were reasons commonly cited by the PCPs for referral to endocrinologists. Some of the other reasons provided included, presence of comorbidities (other endocrine disorders such as T1DM), extreme resistance to insulin, necessity of multiple adjustments to therapy and patient request.
Beliefs about patient self-care
An important objective of the physician survey was to identify the PCPs' perceptions about the importance and level of difficulty of their patient's self-care activities. These activities include regular moderate exercise, following a recommended diet, regular blood glucose testing, proper insulin administration and adherence to oral medication (Table 2) . A majority of PCPs (around 95%) considered the self-care activities as extremely important. A higher degree of variation was observed in the PCPs' perception of the level of difficulty the patients face in performing these activities. However, over half of the PCPs considered regular moderate exercise (85.71%), following a recommended diet (80.95%) and proper insulin administration (61.90%) as at least 'difficult'. Interestingly, over half of the PCPs perceived adherence to medication and regular blood glucose testing as 'slightly difficult' (52%) or 'not difficult at all' (38%). A majority (76.19%) of the PCPs believed that <50% of their patients were adherent to regular moderate exercise or following a recommended diet. However, a majority (60%) also believed that >50% of their patients were adherent to regular blood glucose testing, proper insulin administration and were taking their oral medications as prescribed.
Beliefs about physician practice
All aspects of physician practice such as physician-patient communication, patient health literacy and patient followup were considered extremely important or very important by a majority of the PCPs (95.23-100.00%). Overall, the PCPs rated their performance on these measures positively. A majority of PCPs (over 90%) showed satisfaction with their performance on these measures (Table 3) . A sizable proportion of the PCPs (66.67%) considered themselves to be responsible, to some extent, for their patient's failure to achieve their self-management goals. Interestingly, there was a strong association between physician perceived responsibility of patient's failure to achieve self-management goals and self-rated performance on patient follow-up (v 2 = 27.34, P < 0.001), self-rated satisfaction with patient follow-up (v 2 = 21.83, P < 0.01), and self-rated satisfaction with patient health literacy (v 2 = 17.68, P < 0.01). 
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Reasons for clinical inertia
There were several themes that emerged from the PCPs' responses about the barriers that led to clinical inertia in their practice and these are summarized below. [19, 20] 
Costs
The most common theme in the responses was the costs associated with managing T2DM. Cost of medications was the most cited barrier that led to clinical inertia. Other costs such as those incurred for office visits including copay, costs for purchasing insulin monitoring equipment and additional costs associated with healthy food choices (lean proteins and vegetables) were also mentioned by the PCPs as barriers to intensification of therapy in their T2DM patients.
Patient motivation and interest
A few PCPs noted that lack of patient interest and their unwillingness to change their health-related behaviours prevented the practitioners from intensifying treatment and improving the health outcomes of their patients. One respondent noted, 'The lack of motivation from the patient made the practitioner pessimistic about being able to manage this type of patients'. It was observed by another respondent that 'Patients find it difficult to curb their appetite for good tasting bad foods and prefer to watch TV than exercise'. 'Patients' lack of confidence in guidelines, which are often inconsistent among various organizations that publish them', was cited as another reason for patient's reluctance to change.
Knowledge
The PCPs believed that their patients did not feel they were ill or were in denial about their problems, some being unaware of secondary problems such as blindness and renal failure associated with unmanaged T2DM. Patient's fear of injectable medications and hypoglycaemia also prevented their PCPs from intensifying treatment. One respondent noted that 'there was lack of in-office diabetes education for the patients in their practice' while another respondent found it 'difficult to get the patients to attend diabetes education outside of office visits'.
Noncompliance with diet and medications
Patient's non-compliance with diet, exercise and medications was cited as barriers to treatment intensification by many PCPs. A respondent also mentioned that 'the patients do not keep up with scheduled visits and follow-ups'.
Polypharmacy
The PCPs noted that their patients were already on multiple medications as part of their therapy, and thus, it was difficult for the physicians to add more medications to their treatment regimen. Comorbidities often led to increased number of prescribed medications and could cause drugdrug interactions. Some patients were also reported to develop resistance to oral medications as well as insulin, making treatment difficult. A respondent mentioned that 'newer medications and their changing roles caused the patients and providers to stick to old patterns'. All these factors associated with polypharmacy also lead to clinical inertia according to the survey respondents.
Lack of time
The PCPs acknowledged that they do not have enough time to focus on their patient's diabetes-related complications as the patients often have other chronic illnesses that require their attention during the office visits. Consequentially, the PCPs have to let the patients work on their diet regimen and exercise, without being able to provide much care in that regard. They also believed that the office visits were too few to be able to allocate enough time to address their patients' T2DM-related complications.
Social support
Family dynamics and lack of support from home (family members) to embrace a healthy lifestyle that includes proper diet regimen and regular exercise were reported to be a barrier to treatment intensification by the PCPs.
Miscellaneous
Apart from the aforementioned themes, barriers such as medication side effects, reimbursement issues and patient's frustration due to not reaching goals or seeing immediate results were also reported by the PCPs.
Discussion
The study sought to examine PCPs' perceptions about selfcare behaviours of their patients with T2DM. Overall, the physician group perceived diabetes-related self-care activities to be extremely important for the overall management of T2DM; however, their perceptions about how difficult their patients perceived these activities varied considerably. The PCPs acknowledged that patient-physician communication, patient health literacy and patient follow-up are extremely important aspects of providing quality care to their patients; a majority of them considered their performance on these measures as average or good, with a majority at least satisfied with their performance. PCPs who rated their performance and satisfaction with patient follow-up and satisfaction with patient health literacy poorly were more likely to consider themselves responsible for patient's failure to achieve selfmanagement goals. This finding is consistent with existing literature; a study by Beverly et al. found that physicians who assumed responsibility for their patient's failure to achieve treatment goals were more likely to rate their performance poorly. They appeared to set very high standards for themselves and believed they were not doing enough to help their patients achieve treatment goals. [9] The PCPs overwhelmingly cited unstable nature of their patients' diabetes as a reason for referring them to an endocrinologist. This finding was confirmed in the other part of this study that assessed patient perceived barriers and facilitators to self-management of diabetes where the patients who received a referral to an endocrinologist were found to be more likely to have poor glycaemic stability than those who did not receive a referral. [18] In patients whose A1C levels remain unstable in a primary care setting, it has been suggested that directing the patients to an endocrinologist or diabetes educators who focus on addressing barriers to improving glycaemic stability may produce positive results. [21] An area where the discordance between patient and PCP perceptions was highlighted in this study was the patient's knowledge of the disease. PCPs cited that patients often do not seek follow-up care, as they perceive they have adequate knowledge of the disease. However, in the other part of this study, the patients demonstrated poor knowledge of their disease as measured by the diabetes subsection of the Diabetes, Hypertension and Dyslipidemia (DHL) questionnaire, while believing that they understood their disease well, as measured by the Revised Illness Perception Questionnaire (IPQ-R). [18] Interventions such as Medication Therapy Management (MTM) services or in-clinic patient education can help identify and narrow such gaps in perceptions of patients and their providers. [5, 22] Previous studies have shown that concordance between perceptions of patients and their physicians about self-care behaviours is associated with improved self-care. [5, 8, 23, 24] Successful management of T2DM requires collaborative efforts between patients and their physicians. [24] These efforts involve improving patient-physician communication, patient health literacy and addressing specific barriers to self-care in these patients. [22] [23] [24] [25] Barriers that led to clinical inertia among the PCPs in this study were identified using an open-ended question. Cost of managing diabetes was the most commonly cited barrier. Very few studies looking at the physician barriers in management of patients with T2DM have identified cost of treatment and healthy food choices as a barrier to intensifying treatment in order to achieve target A1c goals. [26] However, other barriers identified in this study, such as patient motivation, knowledge, adherence to diet and medications, physician's lack of time and lack of social support, echo the findings from previous studies. [10, 15, [26] [27] [28] [29] [30] A study by Nam et al. [15] identified physician factors such as their attitudes, beliefs and knowledge, and communication skills that can influence self-management in patients with T2DM. Identifying the barriers that lead to clinical inertia can help develop tailored programmes to improve care and glycaemic stability in patients with T2DM.
Limitations
There were a number of limitations in this study. This study is part of a larger study that assessed the barriers to DSM from the perspectives of both providers and their patients. The patient survey responses were not linked to the PCP responses, which prevents from gaining insights on how the practice-related characteristics translate to glycaemic stability in our sample. Another limitation is the small sample size of the PCPs, although exploratory analyses typically work with even smaller samples. The study results provide key insights about PCP perceptions on diabetes self-care and their barriers in managing patients with T2DM in a primary care setting; however, generalizability of the study results to other practice settings is not possible.
Implications
The study identified different barriers that contribute to clinical inertia and highlighted areas where discordance exists between perceptions of patients and their PCPs; resolving these differences may help improve care and outcomes. Interventions including clinical services that facilitate collaborative relationships between providers and their patients are crucial in enhancing the overall management of T2DM.
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